Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa

Dermatol Ther. 2020 Jul;33(4):e13756. doi: 10.1111/dth.13756. Epub 2020 Jun 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • ixekizumab